Confirmed Plenary Speakers (to Date) |
| Keynote Lecture |
|
Thursday September 8, 2022 |
14:15 | Registration |
|
15:00 | Welcome and Opening |
Dr Maria DUCA (UNIVERSITY OF CÔTE D'AZUR, Nice, France) Prof. Rui MOREIRA (UNIVERSITY OF LISBON, Lisbon, Portugal) |
15:15 | KL01 - "All Models are Wrong, Some are Useful". The Medicinal Chemist is Never Better Than the Biological Models Available to Assess Compound Properties |
Prof. Benoit DEPREZ (INSTITUT PASTEUR DE LILLE, Lille, France) |
15:45 | EFMC-YMCS Competition Presentation Session I |
|
| Session Chair: |
Dr Maria DUCA (UNIVERSITY OF CÔTE D'AZUR, Nice, France) |
15:45 | OC01 - Degrading Into Opportunities: Self-Immolation as Mechanism for Artificial Signal Transduction Winner of the young medicinal chemist meeting in Denmark |
Dr Kaja BORUP LØVSCHALL (TECHNICAL UNIVERSITY OF DENMARK, København Ø, Denmark) |
16:05 | OC02 - From a Helix to a Cycle: Peptide Macrocylization Strategies to Develop New Antimicrobial Agents Winner of the young medicinal chemist meeting in Italy
|
Dr Francesco MERLINO (UNIVERSITY OF NAPLES, FEDERICO II, Naples, Italy) |
16:25 | OC03 - Disruption of Mitochondrial Redox Homeostasis by Enzymatic Activation of a Trialkylphosphine Probe Winner of the young medicinal chemist meeting in Switzerland
|
Ms Jade NGUYEN (EPFL, Geneva, Switzerland) |
16:45 | Flash Poster Presentations (Part I) |
|
| FP01 – Triazine-Based Small Molecules as Novel PD-L1 Modulators |
Ms Giulia ASSONI (UNIVERSITY OF TRENTO, Trento, Italy) |
| FP02 - Synthesis and Preclinical Validation of Limks Inhibitors: Promising Drugs for Osteosarcoma Treatment? |
Mr Rayan BERABEZ (UNIVERSITÉ D'ORLÉANS, ORLEANS, France) |
| FP03 - Development of Encoded Combinatorial Chemistry for The Identification of Specific Ligands of G-Quadruplex DNA Structures |
Dr Gilles DEGOTTE (I2BM/UNIVERSITY GRENOBLE ALPES, Grenoble, France) |
| FP04 - Synthesis and Biological Activity of Novel Azoniaspiro Type Quaternary Fluoroquinolones |
Dr Joanna FEDOROWICZ (MEDICAL UNIVERSITY OF GDANSK, Gdansk, Poland) |
| FP05 - Development of Novel Necroptosis Inhibitors Targeting RIPK1 |
Ms Lara FIDALGO (FF.ULISBOA, Lisboa, Portugal) |
| FP06 - Discovery of JNJ-1245, a Novel and Potent Fluoroallylamide MCL-1 Inhibitor for the Treatment of Hematologic Malignancies |
Dr Soufyan JERHAOUI (JANSSEN PHARMACEUTICA NV, Beerse, Belgium) |
| FP07 - Target-Directed Dynamic Combinatorial Chemistry Towards the Discovery of Sars-Cov-2 Anti-Virals Targeting NSP10 |
Dr Gwenaelle JÉZÉQUEL (HZI, Braunschweig, Germany) |
| FP08 - Panicein a Hydroquinone and Analogs Overcome Chemotherapy Resistance in Cancer Cell |
Mrs Sandra KOVACHKA (UNIVERSITÉ COTE D'AZUR, Nice, France) |
| FP09 - Development of Bioorthogonal Palladium Catalysed Reactions for Specific Anticancer Drug Delivery |
Ms Marine LEFEVRE (UCLOUVAIN, Louvain la Neuve, Belgium) |
| FP10 - Design, Synthesis & Evaluation of Novel Aminopeptidase Inhibitors as Potent Antimalarials |
Ms Mahta MANSOURI (MONASH INSTITUTE OF PHARMACEUTICAL SCIENCES, Parkville, Australia) |
| FP15 - Synthesis and Biological Evaluation of Schistosoma Mansoni Sirtuin2 (SMSIRT2) Inhibitors |
Dr Beatrice NOCE (SAPIENZA, UNIVERSITY OF ROME, Rome, Italy) |
| FP16 - Design, Synthesis and Biological Evaluation of New Rna Ligands Targeting miRNA-210: Modulation of the Circadian Clock for Cancer Therapy |
Mr Marc PANOSETTI (INSTITUT DE CHIMIE DE NICE - UNIVERSITÉ COTE D'AZUR, Nice, France) |
| FP17 - A Small Fluorescent Ligand to Investigate Soluble Epoxide Hydrolase Engagement in Living Cells |
Ms Julia SCHOENFELD (GOETHE-UNIVERSITY, Frankfurt am Main, Germany) |
| FP18 - Bactericidal Autophagy Inhibitors to Treat Recurrent Infections and Cancer |
Mrs Alessandra UGOLINI (FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA (IIT), Genoa, Italy) |
17:15 | Coffee Break & Exhibition |
|
| EFMC-YMCS Competition Presentation Session II |
|
| Session Chair: |
Dr Michele MARI (UNIVERSITY OF URBINO, Urbino, Italy) |
17:35 | OC04 - Epitope Identification, a Case Study: Nanobodies Binding to MGLU5 Receptor Winner of the young medicinal chemist meeting in France |
Ms Floriane ESHAK (UNIVERSITY PARIS CITÉ, Paris, France) |
17:55 | OC05 - Studies on the Synthesis and Anticancer Potential of Novel 2,4-Diaminopyrimidine Derivatives Winner of the young medicinal chemist meeting in Turkey
|
Dr Deniz LENGERLI (GAZI UNIVERSITY FACULTY OF PHARMACY, Ankara, Turkey) |
18:15 | OC06 - Unraveling the Potential of Multicomponent Reactions in Drug Discovery Winner of the young medicinal chemist meeting in Spain |
Mr Pau Nadal RODRÍGUEZ (UNIVERSITY OF BARCELONA, Barcelona, Spain) |
18:35 | EFMC-YMCS Poster Presentation Session 1 (Odd),
Networking & Exhibition |
|
20:30 | End of the Day |
|
Friday September 9, 2022 |
08:40 | EFMC-YMCS Competition Presentation Session III |
|
| Session Chair: |
Dr Stéphane AZOULAY (UNIVERSITY OF CÔTE D'AZUR, Nice, France) |
08:40 | OC07 - Hydrophilic and Lipophilic Derivatives of Protulactone A: Synthesis, Antiproliferative Activity and Sar Analysis Winner of the young medicinal chemist meeting in Serbia |
Ms Sanja DJOKIC (UNIVERSITY OF NOVI SAD, Novi Sad, Serbia) |
09:00 | OC08 - Advances in the Development of Novel Therapeutics Targeting Neurodegenerative Diseases Winner of the young medicinal chemist meeting in Germany (DPhG) |
Dr Steffen POCKES (UNIVERSITY OF REGENSBURG, Regensburg, Germany) |
09:20 | OC09 - Design, Synthesis and Biological Evaluation of Novel P53 Activators by Targeting P53 Protein-Protein Interactions Winner of the young medicinal chemist meeting in Portugal |
Dr Margarida ESPADINHA (UANTWERPEN, Antwerp, Belgium) |
09:40 | OC10 - Elevated Vacuolar Uptake of Fluorescently Labeled Antifungal Drug Caspofungin Predicts Echinocandin Resistance in Pathogenic Yeast Winner of the young medicinal chemist meeting in Israël |
Mr Jaber QAIS (TEL AVIV UNIVERSITY, taiybe, Israel) |
10:00 | Flash Poster Presentations (Part II) |
|
| FP11 - Antibody-Protac Conjugates: An Approach for Targeted Selective BRD4 Degradation in HER2+ Phenotypes |
Dr Maria MANEIRO (UNIVERSIDADE DE SANTIAGO DE COMPOSTELA, Santiago de Compostela, Spain) |
| FP12 - Preclinical Evaluation of Antibody Recruiting Glycodendrimers (ARGs) for Cancer Therapy |
Dr Angela MARTIN SERRANO ORTIZ (UNIVERSITÉ GRENOBLE-ALPES, Grenoble, France) |
| FP13 - Development of Orally Available Cyclic Peptide Therapeutics |
Mr Manuel MERZ (SWISS FEDERAL INSTITUTE OF TECHNOLOGY LAUSANNE (EPFL), Lausanne, Switzerland) |
| FP14 - Sar of Triquinazine, a Class of Potent Janus Kinase Inhibitors |
Ms Kleni MULLIRI (UNIVERSITY OF BERN, Bern, Switzerland) |
| FP19 - Potent and Specific Activators for The Mitochondrial Sirtuins SIRT3 And SIRT5 |
Dr Clemens ZWERGEL (SAPIENZA UNIVERSITY OF ROME, Rome, Italy) |
10:10 | Coffee Break |
|
10:40 | EFMC-YMCS Competition Presentation Session IV |
|
| Session Chair: |
Dr Maja BEUS (INSTITUTE FOR MEDICAL RESEARCH, Durham, United States) |
10:40 | OC11 - A Chemical Biological Approach to Study GPCRS: Labeling the Adenosine A1 Receptor Using an Electrophilic Covalent Probe Winner of the young medicinal chemist meeting in The Netherlands |
Mr Bert BEERKENS (LEIDEN UNIVERSITY, Leiden, The Netherlands) |
11:00 | OC12 - Indole and Pyrazole as Versatile Scaffolds for Biological Active Compounds: New Chimeric Kinase and Bromodomain Inhibitors Winner of the young medicinal chemist meeting in Greece |
Mrs Amalia KALAMPALIKI (NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS, Athens, Greece) |
11:20 | OC13 - The Complementarity Principle in Docking Procedures: Evaluation of the Correctness of Binding Poses Winner of the young medicinal chemist meeting in Croatia
|
Dr Hrvoje RIMAC (UNIVERSITY OF ZAGREB, Zagreb, Croatia) |
11:40 | OC14 - Development of Multifunctional Buche Inhibitors and 5-HT6R Antagonists with Beta-Amyloid Anti-Aggregation Properties as Potential Disease-Modifying Agents against Alzheimer’s Disease Winner of the young medicinal chemist meeting in Poland |
Mr Tomasz WICHUR (UNIWERSYTET JAGIELLONSKI COLLEGIUM MEDICUM , Krakow, Poland) |
12:00 | Lunch, Networking & Exhibition |
|
12:30 | EFMC-YMCS Poster Presentation Session 2 (Even) |
|
13:45 | EFMC-YMCS Competition Presentation Session V |
|
| Session Chair: |
Dr Kristina GONCHARENKO (ZIFO RND SOLUTIONS, Basel, Switzerland) |
13:45 | OC15 - Breaking the Paradigm: Radiolabelled CCK2R Antagonists Are Superior to Radiolabelled Agonists in In Vivo Setting Winner of the young medicinal chemist meeting in Slovenia |
Ms Doroteja NOVAK (UNIVERSITY OF LJUBLJANA, Ljubljana, Slovenia) |
14:05 | OC16 - Discovery, Characterization and Engineering of Ligases for Amide Synthesis Winner of the young medicinal chemist meeting in United Kingdom
|
Mr Michael ROWLINSON (UNIVERSITY OF MANCHESTER, Manchester, United Kingdom) |
14:25 | OC17 - Design, Synthesis, and Preliminary Biological Evaluation of New Boronic Acids Derivatives Winner of the young medicinal chemist meeting in Czech Republic
|
Mr Petr SLECHTA (CHARLES UNIVERSITY, Hradec Králové, Czech Republic) |
14:45 | OC18 - Unravelling HIDO1 Conformational Dynamic to Guide the Discovery of New Inhibitors Winner of the young medicinal chemist meeting in Belgium (SRC) |
Ms Manon MIRGAUX (UNIVERSITÉ DE NAMUR, Namur, Belgium) |
15:05 | OC19 - Fighting Chemistry with Chemistry - New Antidotes against Nerve Agent Intoxication Winner of the young medicinal chemist meeting in Sweden |
Mr Norman HOSTER (UMEA UNIVERSITY, Umea, Sweden) |
15:25 | Voting Break |
|
15:40 | KL02 - Medicinal Chemistry Today: Be Prepared for the Unexpected! |
Dr Gerhard MUELLER (ANAVO THERAPEUTICS, Basel, Germany) |
16:10 | Closing and Award Ceremony |
|
16:30 | End of the Symposium |
|
16:45 | Optional Programme |
|
| Session Chair: |
Dr Kristina GONCHARENKO (ZIFO RND SOLUTIONS, Basel, Switzerland) |
16:45 | EFMC-YSN Soft Skills Training (1) - Reaxys Workshop: A Tandem Tour to Unveil the Profile of An Active Molecule |
Dr Giulia MONCELSI (ELSEVIER LIFE SCIENCES, Amsterdam, The Netherlands) |
17:30 | EFMC-YSN Soft Skills Training (2) - Reaching Out: Effective Communication and Networking for Scientists |
Dr David PERALTA (CHEMMEDCHEM/CHEMISTRY EUROPE, Weinheim, Germany) |
18:15 | End of the Optional Programme |
|